Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Magnasense Technologies

Magnasense Technologies?uq=PEM9b6PF
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Manufacturer of a compact POC (point-of-care) assay system based on antibodies labeled with paramagnetic particles intended to facilitate bio-technology research services. The company offers platform for lateral-flow immunochromatographic tests, which improves sensitivity and precision compared to classical lateral-flow tests enabling to offer robust, affordable, portable, easy to use flexible instruments to human, veterinary, food safety and environmental sectors.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • Rajatorpantie 41 C
  • 01640 Vantaa
  • Finland

+358 040 0000000

Magnasense Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Magnasense Technologies‘s full profile, request access.

Request full access to PitchBook

Magnasense Technologies Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Magnasense Technologies‘s full profile, request access.

Request full access to PitchBook

Magnasense Technologies Executive Team (3)

Name Title Board
Seat
Contact
Info
Mika Laitinen Chief Executive Officer

2 Former Executives

You’re viewing 1 of 3 executives. Get the full list »